Clinical Trials Directory

Trials / Completed

CompletedNCT03797963

Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation

Split-mouth Randomized Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Universidad de Granada · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to evaluate the clinical and radiological behavior, the histological and morphometrical components, the expression of proteins related to bone formation, and the analysis of markers of reparative mesenchymal stromal cells, after using two different xenogenic biomaterials in combination with autogenous cortical bone for maxillary sinus floor elevation. A randomized split-mouth clinical study is designed to include patients in need of two-stage bilateral maxillary sinus floor elevation. Patients will be assigned to receive a mix of autogenous cortical bone (collected by a bone scraper from the access window to the maxillary sinus) and anorganic bovine bone (BioOss Xenograft) in one maxillary sinus or autogenous cortical bone and porcine bone mineral (Symbios Xenograft) in the other maxillary sinus. Cone-beam computerized tomography (CBCT) scans will be performed before and after sinus floor elevation and 6, 12 and 18 months after the procedure to assess the bone gain. Bone core biopsies will be obtained at the site of implant placement 6 months after the floor elevation. Histological sections will be subjected to histomorphometric and immunohistochemical evaluation of differentiation markers.

Conditions

Interventions

TypeNameDescription
DEVICEPBM+ACBMaxillary sinus floor elevation and bone grafting with the use of porcine bone mineral biomaterial (Symbios Xenograft) combined with autogenous cortical bone
DEVICEABB+ACBMaxillary sinus floor elevation and bone grafting with the use of anorganic bovine bone biomaterial (BioOss Xenograft) combined with autogenous cortical bone

Timeline

Start date
2019-01-08
Primary completion
2021-02-02
Completion
2022-02-27
First posted
2019-01-09
Last updated
2023-05-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03797963. Inclusion in this directory is not an endorsement.